Attention Disorders (ADHD)

Home / Neurotech Directory / Attention Disorders (ADHD)

Brief Description

While we know that there are a variety of treatments for ADHD as well as ways to diagnose the condition. How does neurotechnology play into this? Are there options besides being prescribed a pharmaceutical. We are just on the tip of the iceberg in the development but there has been some exciting progress. Take a look. 

The American Psychiatric Association estimates that five percent of children in the U.S. have been diagnosed with ADHD. The worldwide prevalence is slightly higher between 5 to 7 percent. For children ages 4 to 17 in the U.S. approximately 11 percent have the condition, which equates to about 6.4 million children. The condition can be diagnosed in a wide age range including adolescents and adults. It is highly prevalent among males. According to the ADHD Institute, symptoms can be impulsiveness or inattention, the condition often arises alongside other psychiatric conditions such as anxiety disorders or depression.

Research teams out of the University of Texas, Houston and UCLA have been studying and developing trigenminal nerve stimulation for the treatment of ADHD as well as PTSD, depression and even epilepsy. Out of this research came an external stimulation device that stimulates the nerve for a prescribed number of treatments. Another team out of Duke University created a brain training tool called NeuroPlus. The research team showed that children with attention deficit/hyperactivity disorder demonstrated greater focus and decreased hyperactivity and impulsivity after training on the NeuroPlus video games system.

While the potential for both overdiagnosis and underdiagnosis is an important point of concern in ADHD evaluation. A brain analysis system has been developed by NEBA Health, which has the first biomarker cleared by FDA to assist a clinician in ADHD evaluation. Their study shows that this brainwave-based test, NEBA, can reduce overdiagnosis by identifying children whose ADHD like symptoms may be better explained by another condition. Other EEG systems for ADHD are PEER Analytics and B-Alert systems. 


Technology Listing

There are a variety of applications which are listed below by category. Prior to considering any new therapy, treatment or device, a proper evaluation should be conducted with a knowledgeable medical professional. There are health, medical and financial risks. Out of pocket costs and available insurance coverage for any treatment must be considered prior to starting a protocol. Also, it is key to understand that results and applications will vary depended on symptom and function limitations related to the condition. If you find something of interest, please contact the vendor directly to find a trained professional in your area.